CUMYL-4CN-BINACA has been available in the Union since at least October 2015 and has been detected in 11 Member States. Due to the nature of CUMYL-4CN-BINACA, cases of detection are likely to be underreported since CUMYL-4CN-BINACA is not routinely screened for. In most cases, CUMYL-4CN-BINACA was seized as powder or herbal material, but it has also been seized, though to a lesser extent, in other physical forms, for example in blotter form. More than 270 seizures have been made within the Union.
Recital 3, Decision_act (EU) 2018/748
In forcesince 14 May 2018